Rare diseases
Investigational molecules
Locations
A study to evaluate the safety and effectiveness of pegtibatinase in patients aged 12 to 65 years with classical homocystinuria.
BelgiumA study of eloralintide in adults with persistent obesity or overweight who are currently treated with a weekly incretin medication
BelgiumA study to evaluate the safety and effectiveness of NIO752 in patients with progressive supranuclear palsy
BelgiumA study to evaluate the safety and how pivekimab sunirine works in children with relapsed or refractory acute myeloid leukemia
BelgiumA study of sacituzumab tirumotecan versus docetaxel, paclitaxel, or vinflunine for patients with pretreated advanced or metastatic bladder cancer
BelgiumA Phase 3 Study of Elritercept Versus Epoetin Alfa in ESA‑Naïve Adults with Lower‑Risk Myelodysplastic Syndrome Requiring Red Blood Cell Transfusions
BelgiumA Phase 3 Study of Fenfluramine Hydrochloride for Safety and Efficacy in Patients with Rett Syndrome
BelgiumMaintenance Therapy Study of Inavolisib with Pertuzumab and Trastuzumab in Patients with HER2‑Positive, PIK3CA‑Mutated Locally Advanced or Metastatic Breast Cancer
BelgiumPhase 2 Study of Rinatabart Sesutecan with Pegfilgrastim in Adults with Locally Advanced or Metastatic Non-Small Cell Lung Cancer
BelgiumA study to evaluate the effects of KT-621 in adults with moderate to severe eosinophilic asthma
BelgiumA study to evaluate the safety and effectiveness of AAVB-039 in patients with Stargardt disease
BelgiumA study to compare the effectiveness and safety of subcutaneous frexalimab versus intravenous frexalimab in adults with multiple sclerosis
BelgiumTell us about your condition – we search every trial in Europe and connect you with the right site.
